Dialysis Market Regional Analysis:
North American Market Insights
North America region is projected to account for more than 41.3% market share by 2035, driven by rising healthcare expenditure, strong healthcare infrastructure, and supportive regulatory policies. The national health expenditure of the U.S. in 2020, rose by 9.7% and reached USD 4.1 trillion, or USD 12,350 for every person, as per the CMS. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the market players to opt for investing into more research works to bring up more feasible solutions so as to develop efficient treatment options, are also anticipated to contribute to the market growth in the region.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of dialysis is evaluated at USD 122.49 billion.
The global dialysis market size was worth over USD 115.72 billion in 2025 and is poised to grow at a CAGR of around 6.5%, reaching USD 217.22 billion revenue by 2035.
North America dialysis market will secure around 41.3% share by 2035, driven by rising healthcare expenditure, strong healthcare infrastructure, and supportive regulatory policies.
Key players in the market include Baxter International, Inc., Nikkiso Co., Ltd., MEDIVATORS Inc., NIPRO Corporation, Diaverum AB, B. Braun MelsungenAG, DaVita, Inc., Asahi Kasei Corporation, NxStage Medical, Inc., Fresenius Medical Care AG & Co. KGaA.
